Economic Benefits of COVID-19 Screening Tests with a Vaccine Rollout
Andrew Atkeson, Michael Droste, Michael J. Mina, James H. Stock
doi: https://doi.org/10.1101/2021.03.03.21252815
Andrew Atkeson
1Department of Economics, UCLA
Michael Droste
2Department of Economics, Harvard University
Michael J. Mina
3Chan School of Public Heath, Harvard University
James H. Stock
4Department of Economics and Harvard Kennedy School, Harvard University
Article usage
Posted March 05, 2021.
Economic Benefits of COVID-19 Screening Tests with a Vaccine Rollout
Andrew Atkeson, Michael Droste, Michael J. Mina, James H. Stock
medRxiv 2021.03.03.21252815; doi: https://doi.org/10.1101/2021.03.03.21252815
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)